Related Experiment Video
Updated: Nov 20, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and
Andrew R Harper1,2, Anuj Goel1,2, Christopher Grace1,2
1Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
Insights
Genetic factors significantly influence hypertrophic cardiomyopathy (HCM), a serious heart condition. Common genetic variants and modifiable risk factors like blood pressure play key roles in HCM development and severity.
Area of Science:
- Cardiovascular Genetics
- Genomics
- Heart Disease Research
Background:
- Hypertrophic cardiomyopathy (HCM) is a common yet serious genetic heart disorder.
- Existing research links rare sarcomere gene variants to HCM, but this doesn't explain the full picture of phenotypic heterogeneity or cases lacking these variants.
Purpose of the Study:
- To investigate the genetic architecture of HCM beyond rare sarcomere variants.
- To identify common genetic variants and modifiable risk factors contributing to HCM.
- To explore the clinical actionability of genetic insights and risk factors in HCM.
Main Methods:
- Conducted a genome-wide association study (GWAS) involving 2,780 HCM cases and 47,486 controls.
- Calculated single-nucleotide polymorphism (SNP) heritability to assess polygenic influence, particularly in sarcomere-negative HCM.
- Developed and validated a genetic risk score (GRS) for HCM and used Mendelian randomization to identify modifiable risk factors.
Main Results:
- Identified 12 novel genome-wide-significant loci associated with HCM susceptibility.
- Demonstrated a strong polygenic influence on HCM, especially in sarcomere-negative cases (h²g = 0.34 ± 0.02).
- A GRS significantly impacted HCM odds and phenotypic severity; Mendelian randomization linked diastolic blood pressure (DBP) to a fourfold increased HCM risk in sarcomere-negative cases.
Conclusions:
- Common genetic variants play a substantial role in HCM pathogenesis, contributing to phenotypic heterogeneity.
- Modifiable risk factors, notably diastolic blood pressure, are crucial for sarcomere-negative HCM and present actionable targets.
- These findings suggest a paradigm shift towards integrating polygenic risk and modifiable factors for clinical management of HCM.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a common, serious, genetic heart disorder. Rare pathogenic variants in sarcomere genes cause HCM, but with unexplained phenotypic heterogeneity. Moreover, most patients do not carry such variants. We report a genome-wide association study of 2,780 cases and 47,486 controls that identified 12 genome-wide-significant susceptibility loci for HCM. Single-nucleotide polymorphism heritability indicated a strong polygenic influence, especially for sarcomere-negative HCM (64% of cases; h2g = 0.34 ± 0.02). A genetic risk score showed substantial influence on the odds of HCM in a validation study, halving the odds in the lowest quintile and doubling them in the highest quintile, and also influenced phenotypic severity in sarcomere variant carriers. Mendelian randomization identified diastolic blood pressure (DBP) as a key modifiable risk factor for sarcomere-negative HCM, with a one standard deviation increase in DBP increasing the HCM risk fourfold. Common variants and modifiable risk factors have important roles in HCM that we suggest will be clinically actionable.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Pathophysiology of Heart Failure
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

